Association of radiation dose to cardiac substructures with major ischaemic events following breast cancer radiotherapy
Authors' conclusion
Risk of major ischaemic events exist in the era of modern radiotherapy. LV V25 ≥ 4% appeared to be the optimum parameter and was superior to MHD in predicting major ischaemic events.
Study context
- Population
- Women with breast cancer receiving adjuvant radiotherapy
- Participants
- 2,158 women
- Exposure
- Radiation dose to cardiac substructures and major ischaemic events
- Outcome
- Major ischaemic event
Main finding
As reported in the abstract
Major ischaemic events · median follow-up 7.9 years (IQR 5.6-10.8 years)
- Patients developing major ischaemic events
- 89
- Cumulative incidence significantly higher in left-sided disease
- P = 0.044
- Mean heart dose (MHD) increased risk by 6.2% per Gy, HR 1.062 (95% CI 1.01-1.12)
- P = 0.012
Observational data: associations, not effects.
Further findings
Other risk factors for major ischaemic events
- Age, CKD and hyperlipidaemia were significant risk factors
Original publication
Association of radiation dose to cardiac substructures with major ischaemic events following breast cancer radiotherapy. Eur Heart J. Published 16 August 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →